AMY SUGAR: Open Payments
NPI 1891210944 · NILES, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,722 in 81 payments from 15 companies in 2025. Trend: 2023 $2,286 · 2024 $1,787 · 2025 $1,722
Food & beverage: $1,638Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $252 |
| Novo Nordisk Inc | 3 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $189 |
| Phathom Pharmaceuticals, Inc. | 11 | $158 |
| Lilly USA, LLC | 3 | $156 |
| GENZYME CORPORATION | 3 | $146 |
| Ipsen Biopharmaceuticals, Inc | 1 | $143 |
| Madrigal Pharmaceuticals | 4 | $118 |
| Janssen Biotech, Inc. | 2 | $104 |
| PFIZER INC. | 1 | $98 |
Products named: ENTYVIO, DUPIXENT, VOQUEZNA, OMVOH, IQIRVO, REZDIFFRA, Wegovy, TREMFYA.
Industry payments across OH — which companies pay providers there.
